Report Categories
View AllRecent Articles
View All
What Could Drag Blackrock Tech Bstz Stock Lower Price At 22.36 Down 1.06 20260402
ABG Q1 2026 Earnings Miss on EPS Despite Modest Stock Gain
Feds Barkin Says Policy WellPositioned to Address Ongoing Economic Shocks
Pampa PAM Slides 360 as Selling Pressure Mounts 20260520
Dine Brands DIN Craters 144 New Lows Tested 20260521
Reddit Shares Tumble as Meta Launches Standalone Facebook Groups App Forum
Drama Desk Awards Reshape Tony Awards Race Offering Potential Market Signals for Broadway Productions
Eli Lilly Targets Infectious Disease with Nearly 4 Billion Vaccine Deals
Smallcase Managers Forecast Nifty 50 Could Reach 2800030000 by FY27 Amid 9 YTD Decline
WuXi Facility Secures Brazilian GMP Certification for Dengue Vaccine Production
Bank Closures on Memorial Day A Guide to the 12 Federal Holidays
DigitalBridge Group Inc DBRG Q1 2026 Earnings EPS Misses Estimates Amid Digital Infrastructure Headwinds
Accel Entertainment ACEL Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency
Iveda Solutions IVDA Q2 2024 Earnings Narrower Loss Beats Expectations Despite Revenue Uncertainty
CLH Q1 2026 Earnings Earnings Beat Supports Positive Market Sentiment
SES AI Corporation Q1 2026 Earnings EPS Misses Estimates Amid Continued PreRevenue Phase
Atea Pharmaceuticals AVIR Gains 425 as Stock Tests Key Resistance Level
CenterPoint Energy CNP Edges Higher Resilience in a Volatile Utility Landscape
Rio Tinto RIO Slides 115 as Commodity Headwinds Persist Support at 10042 in Focus
Akebia Therapeutics AKBA Holds Steady at 102 as Stock Consolidates Near Key Support
Tenaris TS Q1 2026 Earnings EPS Beat Drives Upbeat Outlook Yet Shares Slip
CRNX Q1 2026 Earnings EPS Surprise Beats Estimates as PreRevenue Biotech Advances Pipeline
FWONA Q4 2025 Earnings Narrow EPS Miss Amid Steady Formula One Operations
IGIC Q1 2026 Earnings EPS Miss Sends Shares Lower as Profitability Challenges Emerge
EIKN Q1 2026 Earnings WiderthanExpected Loss as Clinical Development Intensifies
CRDL Q4 2025 Earnings Narrower Loss Surpasses Estimates Amid Clinical Progress